Evaluating upper limb performance in children with myelomeningocele during dual tasks
Comparison of Dual Task and Upper Extremity Performance in Children With Myelomeningocele and Typically Developing Peers
Abant Izzet Baysal University · NCT06949475
This study tests how well children with myelomeningocele can use their hands while doing two things at once, to better understand their daily challenges.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 46 (estimated) |
| Ages | 7 Years to 18 Years |
| Sex | All |
| Sponsor | Abant Izzet Baysal University (other) |
| Locations | 1 site (Merkez, Bolu) |
| Trial ID | NCT06949475 on ClinicalTrials.gov |
What this trial studies
This observational study assesses the upper extremity performance of children with myelomeningocele while they perform dual tasks. Participants will undergo single task evaluations using the Box Block Test and the Nine Hole Peg Test, followed by dual task assessments that combine these tests with cognitive and motor tasks. The study aims to measure the 'dual task effect' to determine how well these children can manage multiple tasks simultaneously. Data will be collected on socio-demographic information and performance metrics to better understand the challenges faced by these children in daily activities.
Who should consider this trial
Good fit: Ideal candidates include children aged 7-18 diagnosed with myelomeningocele or typically developing children without musculoskeletal issues.
Not a fit: Patients who have undergone recent surgery or have severe visual or hearing impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved strategies for enhancing daily functioning and independence in children with myelomeningocele.
How similar studies have performed: While dual task performance has been studied in adults with various conditions, this approach in pediatric populations with myelomeningocele is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: For children with meningomyelocele * To be between the ages of 7-18 * To have been diagnosed with meningomyelocele * To have scored 27 points or more on the modified mini mental test For children with typical developing * Being between the ages of 7-18 years * Having no typically developing musculoskeletal problems and volunteering to participate in the study * Not having a chronic neurological, cardiovascular or orthopedic disease * Having a score of 27 or above on the modified mini mental test Exclusion Criteria: For children with meningomyelocele * Not agreeing to participate in the study, * Having undergone surgery or Botolunium toxin administration within the last six months * Having suffered a fracture of the upper extremity within the last six months For children with typical developing * Having severe visual or hearing impairment * Having attention problems to the extent that they cannot understand the assessment instructions * Having a musculoskeletal, cardiovascular, pulmonary, metabolic or other disease severe enough to prevent participation in the study.
Where this trial is running
Merkez, Bolu
- Bolu abant Izzet Baysal University — Merkez, Bolu, Turkey (RECRUITING)
Study contacts
- Principal investigator: Sezen Tezcan, Ph.D — Abant Izzet Baysal University
- Study coordinator: Sezen Tezcan
- Email: fztsezen@windowslive.com
- Phone: +905445723731
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Meningomyelocele, Dual task, Upper extremity performance